Pregnancy and Behçet Syndrome: A Large Retrospective Italian Study
- PMID: 40719635
- DOI: 10.1111/aji.70133
Pregnancy and Behçet Syndrome: A Large Retrospective Italian Study
Abstract
Introduction: Behçet syndrome (BS) is a multifactorial disorder with several clinical manifestations that occurs during the childbearing age. The relationship between pregnancy and BS has been previously analysed as the pregnancy immunometabolic reprogramming in case of autoinflammatory and/or autoimmune diseases can influence both the course of the disease and the pregnancy outcomes. We aim to analyse the relationship between BS and pregnancy, investigating: (1) the prevalence and clinical characteristics of disease flares during pregnancy and (2) the pregnancy outcomes in a large cohort of Italian patients with BS.
Methods: This retrospective study was conducted recruiting a cohort of BS patients according to the criteria of the International Study Group for Behçet (ISG), following at the Rheumatology Department of Lucania (San Carlo Hospital, Potenza) from January 2000 to December 2021. We reviewed medical records and collected demographic and clinical data besides pregnancy-related data, in particular: maternal age, disease flares during and after pregnancy, post-partum maternal and neonatal complications (up to 6 months after pregnancy).
Results: We studied 153 pregnancies in 96/117 subjects (21/117 patients did not get pregnant). Three patients showed active disease (oral ulcers) at the time of conception. Disease flares were observed during gestation for 25/153 (16.3%) pregnancies, mainly mucocutaneous (oral and genital ulcers, erythema nodosum) and joint (arthralgia and arthritis) manifestations. A total of 27/153 (17.6%) cases of disease flares were observed after pregnancy, with mucocutaneous (oral and genital ulcers, erythema nodosum) and joint (arthralgia and arthritis) involvement, as well as anterior uveitis. Miscarriages, preterm delivery, pre-eclampsia and eclampsia were observed in 27/153 (17.6%), 19/153 (12.4%), 6/153 (3.9%) and 2/153 (1.3%) pregnancies, respectively. No cases of neonatal complications or death were observed.
Conclusions: The results of the present study underlined that: (a) BS disease clinical symptoms do not appear to worsen during pregnancy and (b) the pregnancy does not appear to be associated with increased gestational complications and adverse maternal-fetal outcomes in case of BS. However, due to the potential adverse events, especially of the vascular involvement, a strong multidisciplinary pregnancy follow-up is recommended.
Keywords: Behçet syndrome; immune reprogramming; pregnancy.
© 2025 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
-
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.Cochrane Database Syst Rev. 2016 Jun 7;2016(6):CD005542. doi: 10.1002/14651858.CD005542.pub3. Cochrane Database Syst Rev. 2016. PMID: 27272351 Free PMC article.
-
Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.Cochrane Database Syst Rev. 2016 Jul 12;7(7):CD008968. doi: 10.1002/14651858.CD008968.pub3. Cochrane Database Syst Rev. 2016. PMID: 27404120 Free PMC article.
-
Incentives for increasing prenatal care use by women in order to improve maternal and neonatal outcomes.Cochrane Database Syst Rev. 2015 Dec 15;2015(12):CD009916. doi: 10.1002/14651858.CD009916.pub2. Cochrane Database Syst Rev. 2015. PMID: 26671418 Free PMC article.
References
-
- M. C. Padula, P. Leccese, N. Lascaro, et al., “Correlation of Tumor Necrosis Factor‐α ‐308G>a Polymorphism With Susceptibility, Clinical Manifestations, and Severity in Behçet Syndrome: Evidences From an Italian Genetic Case‐Control Study,” DNA and Cell Biology 39, no. 7 (2020): 1104–1110.
-
- P. Leccese, M. C. Padula, N. Lascaro, A. A. Padula, and S. D'Angelo, “Clinical Phenotypes of Behçet's Syndrome in a Large Cohort of Italian Patients: Focus on Gender Differences,” Scandinavian Journal of Rheumatology 50, no. 6 (2021): 475–478.
-
- S. Lavalle, S. Caruso, R. Foti, et al., “Behçet's Disease, Pathogenesis, Clinical Features, and Treatment Approaches: A Comprehensive Review,” Medicina (Kaunas, Lithuania) 60, no. 4 (2024): 562.
-
- M. Arbrile, M. Radin, D. Rossi, E. Menegatti, D. Roccatello, and S. Sciascia, “Pregnancy Outcomes in Behçet's Disease: Results From a Monocentric Cohort,” Journal of Reproductive Immunology 153 (2022): 103682.
-
- D. Bang, Y. S. Chun, I. B. Haam, E. S. Lee, and S. Lee, “The Influence of Pregnancy on Behçet's Disease,” Yonsei Medical Journal 38, no. 6 (1997): 437–443.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical